Chronic Myelomonocytic Leukemia Completed Phase 1 / 2 Trials for Decitabine (DB01262)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01165996Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic SyndromeTreatment